CEGEDIM SA (ALCGM.PA) Fundamental Analysis & Valuation

EPA:ALCGM • FR0000053506

10.15 EUR
+0.05 (+0.5%)
Last: Mar 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This ALCGM.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Overall ALCGM gets a fundamental rating of 3 out of 10. We evaluated ALCGM against 12 industry peers in the Health Care Technology industry. ALCGM may be in some trouble as it scores bad on both profitability and health. ALCGM is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. ALCGM.PA Profitability Analysis

1.1 Basic Checks

  • ALCGM had negative earnings in the past year.
  • ALCGM had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: ALCGM reported negative net income in multiple years.
  • ALCGM had a positive operating cash flow in each of the past 5 years.
ALCGM.PA Yearly Net Income VS EBIT VS OCF VS FCFALCGM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

  • ALCGM has a Return On Assets of -1.40%. This is comparable to the rest of the industry: ALCGM outperforms 41.67% of its industry peers.
  • ALCGM has a Return On Equity (-5.21%) which is in line with its industry peers.
  • ALCGM has a Return On Invested Capital (5.28%) which is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ALCGM is significantly below the industry average of 8.30%.
  • The 3 year average ROIC (2.87%) for ALCGM is below the current ROIC(5.28%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.4%
ROE -5.21%
ROIC 5.28%
ROA(3y)-0.25%
ROA(5y)0.74%
ROE(3y)-1.16%
ROE(5y)2.61%
ROIC(3y)2.87%
ROIC(5y)3.89%
ALCGM.PA Yearly ROA, ROE, ROICALCGM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • Looking at the Operating Margin, with a value of 6.78%, ALCGM is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • ALCGM's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 20.65%, ALCGM is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
  • ALCGM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.78%
PM (TTM) N/A
GM 20.65%
OM growth 3Y-6.64%
OM growth 5Y-3.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.96%
GM growth 5Y-1.7%
ALCGM.PA Yearly Profit, Operating, Gross MarginsALCGM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ALCGM.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALCGM is still creating some value.
  • Compared to 1 year ago, ALCGM has more shares outstanding
  • The number of shares outstanding for ALCGM has been reduced compared to 5 years ago.
  • Compared to 1 year ago, ALCGM has a worse debt to assets ratio.
ALCGM.PA Yearly Shares OutstandingALCGM.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALCGM.PA Yearly Total Debt VS Total AssetsALCGM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • ALCGM has an Altman-Z score of 1.27. This is a bad value and indicates that ALCGM is not financially healthy and even has some risk of bankruptcy.
  • ALCGM has a Altman-Z score of 1.27. This is comparable to the rest of the industry: ALCGM outperforms 41.67% of its industry peers.
  • The Debt to FCF ratio of ALCGM is 5.84, which is a neutral value as it means it would take ALCGM, 5.84 years of fcf income to pay off all of its debts.
  • ALCGM has a Debt to FCF ratio (5.84) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.11 is on the high side and indicates that ALCGM has dependencies on debt financing.
  • ALCGM has a Debt to Equity ratio (1.11) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 5.84
Altman-Z 1.27
ROIC/WACC1.05
WACC5.01%
ALCGM.PA Yearly LT Debt VS Equity VS FCFALCGM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • ALCGM has a Current Ratio of 0.93. This is a bad value and indicates that ALCGM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ALCGM has a worse Current ratio (0.93) than 66.67% of its industry peers.
  • A Quick Ratio of 0.91 indicates that ALCGM may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.91, ALCGM is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.91
ALCGM.PA Yearly Current Assets VS Current LiabilitesALCGM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ALCGM.PA Growth Analysis

3.1 Past

  • ALCGM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -763.97%.
  • The Revenue has been growing slightly by 3.79% in the past year.
  • ALCGM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.38% yearly.
EPS 1Y (TTM)-763.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.96%
Revenue 1Y (TTM)3.79%
Revenue growth 3Y7.65%
Revenue growth 5Y5.38%
Sales Q2Q%1.1%

3.2 Future

  • Based on estimates for the next years, ALCGM will show a very strong growth in Earnings Per Share. The EPS will grow by 22.65% on average per year.
  • Based on estimates for the next years, ALCGM will show a small growth in Revenue. The Revenue will grow by 2.13% on average per year.
EPS Next Y4.72%
EPS Next 2Y21.08%
EPS Next 3Y22.65%
EPS Next 5YN/A
Revenue Next Year0.79%
Revenue Next 2Y1.71%
Revenue Next 3Y2.13%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALCGM.PA Yearly Revenue VS EstimatesALCGM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
ALCGM.PA Yearly EPS VS EstimatesALCGM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

6

4. ALCGM.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALCGM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • ALCGM is valuated cheaply with a Price/Forward Earnings ratio of 5.95.
  • Based on the Price/Forward Earnings ratio, ALCGM is valued cheaper than 100.00% of the companies in the same industry.
  • ALCGM is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.60, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 5.95
ALCGM.PA Price Earnings VS Forward Price EarningsALCGM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

  • 100.00% of the companies in the same industry are more expensive than ALCGM, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALCGM indicates a rather cheap valuation: ALCGM is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.6
EV/EBITDA 2.84
ALCGM.PA Per share dataALCGM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

  • ALCGM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as ALCGM's earnings are expected to grow with 22.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.08%
EPS Next 3Y22.65%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALCGM.PA Dividend Analysis

5.1 Amount

  • ALCGM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALCGM.PA Fundamentals: All Metrics, Ratios and Statistics

CEGEDIM SA

EPA:ALCGM (3/6/2026, 7:00:00 PM)

10.15

+0.05 (+0.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)10-23
Earnings (Next)03-26
Inst Owners14.12%
Inst Owner ChangeN/A
Ins Owners58.96%
Ins Owner ChangeN/A
Market Cap143.12M
Revenue(TTM)658.00M
Net Income(TTM)-13.82M
Analysts44.44
Price Target12.92 (27.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)4.72%
EPS NY rev (3m)6.29%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.66%
Revenue NY rev (3m)-0.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.95
P/S 0.22
P/FCF 2.6
P/OCF 1.05
P/B 0.54
P/tB N/A
EV/EBITDA 2.84
EPS(TTM)-0.98
EYN/A
EPS(NY)1.71
Fwd EY16.81%
FCF(TTM)3.9
FCFY38.41%
OCF(TTM)9.69
OCFY95.46%
SpS46.67
BVpS18.8
TBVpS-11.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.4%
ROE -5.21%
ROCE 7.18%
ROIC 5.28%
ROICexc 5.74%
ROICexgc 22.49%
OM 6.78%
PM (TTM) N/A
GM 20.65%
FCFM 8.35%
ROA(3y)-0.25%
ROA(5y)0.74%
ROE(3y)-1.16%
ROE(5y)2.61%
ROIC(3y)2.87%
ROIC(5y)3.89%
ROICexc(3y)3.13%
ROICexc(5y)4.15%
ROICexgc(3y)11.62%
ROICexgc(5y)15.26%
ROCE(3y)3.91%
ROCE(5y)5.29%
ROICexgc growth 3Y0.21%
ROICexgc growth 5Y-3.19%
ROICexc growth 3Y-3.24%
ROICexc growth 5Y-2.52%
OM growth 3Y-6.64%
OM growth 5Y-3.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.96%
GM growth 5Y-1.7%
F-Score5
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 1.11
Debt/FCF 5.84
Debt/EBITDA 2.02
Cap/Depr 80.74%
Cap/Sales 12.41%
Interest Coverage 3.25
Cash Conversion 93.73%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.91
Altman-Z 1.27
F-Score5
WACC5.01%
ROIC/WACC1.05
Cap/Depr(3y)92.57%
Cap/Depr(5y)94.88%
Cap/Sales(3y)13.24%
Cap/Sales(5y)13.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-763.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.96%
EPS Next Y4.72%
EPS Next 2Y21.08%
EPS Next 3Y22.65%
EPS Next 5YN/A
Revenue 1Y (TTM)3.79%
Revenue growth 3Y7.65%
Revenue growth 5Y5.38%
Sales Q2Q%1.1%
Revenue Next Year0.79%
Revenue Next 2Y1.71%
Revenue Next 3Y2.13%
Revenue Next 5YN/A
EBIT growth 1Y122.96%
EBIT growth 3Y0.5%
EBIT growth 5Y1.66%
EBIT Next Year289.41%
EBIT Next 3Y64.73%
EBIT Next 5YN/A
FCF growth 1Y89.23%
FCF growth 3Y-27.43%
FCF growth 5YN/A
OCF growth 1Y24.18%
OCF growth 3Y2%
OCF growth 5Y28.33%

CEGEDIM SA / ALCGM.PA FAQ

What is the ChartMill fundamental rating of CEGEDIM SA (ALCGM.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALCGM.PA.


What is the valuation status for ALCGM stock?

ChartMill assigns a valuation rating of 6 / 10 to CEGEDIM SA (ALCGM.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for CEGEDIM SA?

CEGEDIM SA (ALCGM.PA) has a profitability rating of 3 / 10.


Can you provide the financial health for ALCGM stock?

The financial health rating of CEGEDIM SA (ALCGM.PA) is 2 / 10.


Can you provide the dividend sustainability for ALCGM stock?

The dividend rating of CEGEDIM SA (ALCGM.PA) is 0 / 10 and the dividend payout ratio is 0%.